{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:49:57Z","timestamp":1792673397881,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.juro.2016.08.081","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T16:34:02Z","timestamp":1471883642000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance"],"prefix":"10.1097","volume":"197","author":[{"given":"Fang","family":"Zhao","sequence":"first","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Olkhov-Mitsel","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus","family":"van der Kwast","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Pathology, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Sykes","sequence":"additional","affiliation":[{"name":"St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Zdravic","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasundara","family":"Venkateswaran","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre R.","family":"Zlotta","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Department of Urology and Surgical Oncology, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Loblaw","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Fleshner","sequence":"additional","affiliation":[{"name":"Department of Urology and Surgical Oncology, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Klotz","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Vesprini","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharati","family":"Bapat","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Pathology, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2016.08.081_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2016.08.081_bib2","doi-asserted-by":"crossref","first-page":"e4830","DOI":"10.1371\/journal.pone.0004830","article-title":"Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays","volume":"4","author":"Kron","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.juro.2016.08.081_bib3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/labinvest.2010.57","article-title":"DNA methylation of HOXD3 as a marker of prostate cancer progression","volume":"90","author":"Kron","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.juro.2016.08.081_bib4","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/ijc.25908","article-title":"Association of tissue promoter methylation levels of APC, TGF\u03b22, HOXD3 and RASSF1A with prostate cancer progression","volume":"129","author":"Liu","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2016.08.081_bib5","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1158\/1078-0432.CCR-11-2901","article-title":"Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer","volume":"18","author":"Kron","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2016.08.081_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4161\/epi.21524","article-title":"Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer","volume":"7","author":"Olkhov-Mitsel","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.juro.2016.08.081_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2016.08.081_bib8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.juro.2006.06.103","article-title":"Modeling prostate specific antigen kinetics in patients on active surveillance","volume":"176","author":"Zhang","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2016.08.081_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MOU.0000000000000158","article-title":"Defining 'progression' and triggers for curative intervention during active surveillance","volume":"25","author":"Klotz","year":"2015","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2016.08.081_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jmri.24710","article-title":"A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance","volume":"41","author":"Da Rosa","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.juro.2016.08.081_bib11","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1038\/srep04432","article-title":"Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids","volume":"4","author":"Olkhov-Mitsel","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.juro.2016.08.081_bib12","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","article-title":"MethyLight: a high-throughput assay to measure DNA methylation","volume":"28","author":"Eads","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.juro.2016.08.081_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2016.08.081_bib14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.juro.2016.08.081_bib15","series-title":"Clinical Prediction Models A Practical Approach to Development, Validation, and Updating. Statistics for Biology and Health","author":"Steyerberg","year":"2009"},{"key":"10.1016\/j.juro.2016.08.081_bib16","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","article-title":"Reporting recommendations for tumor marker prognostic studies","volume":"23","author":"McShane","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2016.08.081_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/bjc.2015.7","article-title":"A urine-based methylation signature for risk stratification within low-risk prostate cancer","volume":"112","author":"Jatkoe","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2016.08.081_bib18","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/1078-0432.CCR-06-2467","article-title":"Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage","volume":"13","author":"Roupr\u00eat","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2016.08.081_bib19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2007.094912","article-title":"Development of a multiplexed urine assay for prostate cancer diagnosis","volume":"54","author":"Vener","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2016.08.081_bib20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0090-4295(02)01949-0","article-title":"Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer","volume":"60","author":"Jeronimo","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2016.08.081_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ncponc0966","article-title":"Active surveillance for favorable-risk prostate cancer: who, how and why?","volume":"4","author":"Klotz","year":"2007","journal-title":"Nat Clin Pract Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716310679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716310679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2016.08.081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:46:09Z","timestamp":1651193169000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2016.08.081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1016\/j.juro.2016.08.081"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2016.08.081","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2016.08.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}